BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 15606545)

  • 1. A review of gene therapy for haematological disorders.
    Nathwani AC; Davidoff AM; Linch DC
    Br J Haematol; 2005 Jan; 128(1):3-17. PubMed ID: 15606545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current status and prospects for gene therapy.
    Nathwani AC; Benjamin R; Nienhuis AW; Davidoff AM
    Vox Sang; 2004 Aug; 87(2):73-81. PubMed ID: 15355497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospects for gene therapy of haemophilia.
    Nathwani AC; Davidoff AM; Tuddenham EG
    Haemophilia; 2004 Jul; 10(4):309-18. PubMed ID: 15230943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene therapy for lympho-hematopoietic disorders.
    Thrasher AJ; Gaspar HB
    Curr Hematol Rep; 2005 Jul; 4(4):305-9. PubMed ID: 16009046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progress towards hematopoietic stem cell gene therapy.
    Kurre P; Kiem HP
    Curr Opin Mol Ther; 2000 Aug; 2(4):400-11. PubMed ID: 11249770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retroviral vectors: new applications for an old tool.
    Barquinero J; Eixarch H; PĂ©rez-Melgosa M
    Gene Ther; 2004 Oct; 11 Suppl 1():S3-9. PubMed ID: 15454951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Recent developments in gene therapy].
    Vandendriessche T
    Verh K Acad Geneeskd Belg; 2004; 66(4):305-17; discussion 317-20. PubMed ID: 15553101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on gene therapy for hereditary hematological disorders.
    Herzog RW; Arruda VR
    Expert Rev Cardiovasc Ther; 2003 Jul; 1(2):215-32. PubMed ID: 15030282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A roadmap to safe, efficient, and stable lentivirus-mediated gene therapy with hematopoietic cell transplantation.
    Neschadim A; McCart JA; Keating A; Medin JA
    Biol Blood Marrow Transplant; 2007 Dec; 13(12):1407-16. PubMed ID: 18022569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The leukemogenic risk of integrating retroviral vectors in hematopoietic stem cell gene therapy applications.
    Kang EM; Tisdale JF
    Curr Hematol Rep; 2004 Jul; 3(4):274-81. PubMed ID: 15217557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Occurrence of leukaemia following gene therapy of X-linked SCID.
    Kohn DB; Sadelain M; Glorioso JC
    Nat Rev Cancer; 2003 Jul; 3(7):477-88. PubMed ID: 12835668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medicine. Gene therapy--new challenges ahead.
    Williams DA; Baum C
    Science; 2003 Oct; 302(5644):400-1. PubMed ID: 14563994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hematopoietic malignancies and gene therapy].
    Ozawa K
    Gan To Kagaku Ryoho; 2003 Apr; 30(4):478-82. PubMed ID: 12722677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hematopoietic stem cell gene therapy: dead or alive?
    Ferguson C; Larochelle A; Dunbar CE
    Trends Biotechnol; 2005 Dec; 23(12):589-97. PubMed ID: 16216357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is it going to be SIN?: a European Society of Gene Therapy commentary. Phasing-out the clinical use of non self-inactivating murine leukemia virus vectors: initiative on hold.
    Buchholz CJ; Cichutek K
    J Gene Med; 2006 Oct; 8(10):1274-6. PubMed ID: 17001625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in retrovirus vector-mediated gene therapy: teaching an old vector new tricks.
    Weber E; Anderson WF; Kasahara N
    Curr Opin Mol Ther; 2001 Oct; 3(5):439-53. PubMed ID: 11699888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Gene therapy of severe combined immunodeficiency disease: proof of principle of efficiency and safety issues. Gene therapy, primary immunodeficiencies, retrovirus, lentivirus, genome].
    Fischer A; Hacein-Bey-Abina S; Lagresle C; Garrigue A; Cavazana-Calvo M
    Bull Acad Natl Med; 2005 May; 189(5):779-85; discussion 786-8. PubMed ID: 16433450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene therapy for severe combined immune deficiency.
    Qasim W; Gaspar HB; Thrasher AJ
    Expert Rev Mol Med; 2004 Jul; 6(13):1-15. PubMed ID: 15236670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic modification of hematopoietic stem cells with nonviral systems: past progress and future prospects.
    Papapetrou EP; Zoumbos NC; Athanassiadou A
    Gene Ther; 2005 Oct; 12 Suppl 1():S118-30. PubMed ID: 16231044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular gene therapy.
    Lee JH; Klein HG
    Hematol Oncol Clin North Am; 1995 Feb; 9(1):91-113. PubMed ID: 7737946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.